SplixData
Try the Platform

Trusted AI for
biopharma decisions

We build AI empowered platform that curate data and convert it into insight—powering faster and better decisions for the biotech and biopharma industry.

Schedule a Demo

One platform. End-to-end intelligence.

Connect → Curate → Embed → Reason → Deliver. Built on Postgres + pgvector, private RAG, and a domain ontology for biopharma.

  • Unified Evidence Engine
    Literature, patents, targets, pipelines, filings and financing signals in one graph.
  • Domain AI + RAG
    Scientific-grade retrieval augmented generation grounded by curated ontologies.
  • Actionable Signals
    Competitive moves, trial changes, safety letters, and BD-relevant events in real time.
  • Enterprise-Ready
    SOC2-ready posture, VPC/private deploy, PII-safe pipelines, full audit trail.
Platform Architecture

Connect

PubMed •USPTO •ClinicalTrials •SEC/EDGAR

Curate

Normalization •De-dup •Ontologies

Embed

pgvector •Cross encoders

Reason

RAG Guardrails •Tool use •Audit chain

Deliver

Dashboard •API •Exports
USE CASE 01

Marketing trend analysis

We track events across 3,000+ biotech and pharma companies.

  • Emerging technologies and new clinical trials
  • Financings, partnerships, and M&A
  • Drug cells and company filings
  • Competitor landscape
  • Creating marketing reports
See it in action

Clinical Trial Updates

Last 7 days
Company
Phase
Indication
Status
Vertex Pharma
Phase 3
Cystic Fibrosis
Active
Moderna Inc
Phase 2
Cancer Vaccine
Recruiting
BioNTech SE
Phase 1
Melanoma
Enrolling
Regeneron
Phase 3
Oncology
Active

AI-Generated Insights

Partnership Activity Surge

M&A activity increased 24% this quarter, with oncology partnerships leading the trend.

Key Competitor Moves

3 major players filed new patents in immunotherapy space within the past 30 days.

Emerging Opportunities

Cell therapy sector shows 15+ new clinical trials initiated this month.

Partnership KOL Dashboard
USE CASE 02

Find potential partnership

Identify KOLs, map influence networks, and highlight company pipelines with the best partnership fit for your therapeutic area.

Learn more
USE CASE 03

Whole project evaluation for investors

We provide biotech investors with an end-to-end view of any project.

  • End-to-end project diligence for biotech investors
  • Disease prevalence, current trials, and competitor landscape
  • Market sizing and revenue projections
  • Target druggability assessment
  • Safety and efficacy readouts and risk analysis
  • Probabilities of success based on comparable programs
  • Delivered as a concise, investment-grade report
Request a sample report
Investment Report Dashboard

Join SplixData

We’re hiring founding engineers and data scientists to build the scientific reasoning engine for biopharma.

  • Founding Full‑Stack Engineer (React/Next, Node, AWS)
  • AI/ML Engineer (RAG, pgvector, Guardrails)
  • BioNLP Scientist (LLM, ontologies, curation)
See open roles
Why work with us
Mission-first impact
Senior remote team
Equity + benefits
Scientist/engineer culture

Schedule a strategy demo

See how SplixData accelerates drug & target insights with trusted AI. We’ll tailor to Pharma R&D, BD, or investor workflows.

  • Private & secure trial environment
  • White‑glove onboarding
Open calendar
Your calendaring embed goes here (Calendly/Re:Schedule)